Archive

QBE names Ed Rainsford CRO for Australia and Pacific

FWU insolvency could spook Italian life market

Fitch Ratings warns situation could provoke reactions similar to Eurovita collapse

Gallagher Re predicts up to $2bn in insured losses from Debby

Generali's premiums rise 20% in H1

AM Best highlights strong performance of its rated US captives

Reinsurers' structural changes protect them from severe convective storm losses

S&P Global Ratings says insured losses from severe convective storms have surged

CRO Forum adds social fragmentation to 2024 emerging risks radar

Economic trade conflicts and sanctions have also been included as emerging risks to watch

Japan's insurers preparing to accept more cancer-related risks

S&P Global Ratings says market enjoys high and stable profit margins

QBE exits non-core North American business in $1.6bn LPT transactions

Enstar and RiverStone are assuming risks, and some assets of Australian underwriter

Re/insurers consider a different outcome from cancer

Once a probable death knell, a cancer diagnosis is increasingly becoming a chronic disease, thanks to advances in testing and treatment. This has significant implications for life and health re/insurers, as David Walker reports